shanghai pharmaceuticals-a
(601607:Shanghai Stock Exchange)
shanghai pharmaceuticals-a (601607) Snapshot
|
Open
--
|
Previous Close
--
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
-- - --
|
52 Week Low
-- - --
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
--
|
Shares Outstanding
0.0
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
shanghai pharmaceuticals-a (601607) Related Businessweek News
No Related Businessweek News Foundshanghai pharmaceuticals-a (601607) Details
Shanghai Pharmaceuticals Holding Co., Ltd. engages in pharmaceutical research and development, manufacturing, distribution, and retailing activities primarily in the People’s Republic of China. The company’s Production segment is involved in the research and development, manufacturing, and sale of a range of pharmaceutical and healthcare products. Its Distribution segment engages in the provision of distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. The company’s Retail segment operates a network of retail pharmacy stores. As of December 31, 2012, it had approximately 1,792 chain retail pharmacies under its brand family, including 1,270 directly operated pharmacies. The company is also involved in manufacture and distribution of Chinese medicine; research, development, manufacture, and trade of medicine and medical equipment; assets management and investment consultation in pharmaceutical system; and property rental activities. In addition, it imports and exports medical equipment, medicines, and chemical raw materials. The company is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharma Group.
Last Reported Date: 03/26/13
shanghai pharmaceuticals-a (601607) Top Compensated Officers
shanghai pharmaceuticals-a (601607) Key Developments
Shanghai Pharmaceuticals Holding Co., Ltd., Board Meeting, Apr 26, 2013. Agenda: To discuss and approve the first quarter report of 2013; to consider the proposal of electing directors of 5th Directorate; and to consider the proposal of adjusting allowance of independent directors.
Shanghai Pharmaceuticals Holding Co., Ltd. announced that they will report Q1, 2013 results on Apr 27, 2013
Shanghai Pharmaceuticals Holding Co., Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, total revenue was RMB 19,590,198,049.21 against RMB 16,657,603,310.67 a year ago. Operating profit was RMB 885,915,212.91 against RMB 811,121,906.99 a year ago. Total profit was RMB 894,585,043.38 against RMB 831,463,472.17 a year ago. Net profit attributable to equity holders of the company was RMB 625,664,019.79 or RMB 0.2327 per basic and diluted share against RMB 576,568,772.74 or RMB 0.2144 per basic and diluted share a year ago. Net cash used in operating activities was RMB 257,826,245.93 against RMB 24,476,406.64 a year ago. Cash paid to acquire fixed assets, intangible assets and other long-term assets was RMB 254,629,746.75 against RMB 116,668,810.26 a year ago.
| Recently Viewed | |||
| 601607:CH | CNY12.28 CNY | +0.12 | |
| Company | Last | Change | |
| No competitor information is available for 601607. | |||
| View Industry Companies | |||
Industry Analysis
601607
Industry Average
| Valuation | 601607 | Industry Range |
| Price/Earnings | 16.0x |
|
| Price/Sales | 0.5x |
|
| Price/Book | 1.3x |
|
| Price/Cash Flow | 11.3x |
|
| TEV/Sales | 0.0x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








